Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Development of HIV gene therapy discontinued

Feb. 13, 1998

Remune is safe and well tolerated in the treatment of HIV infection

Feb. 13, 1998

Safety and efficacy of thalidomide in HIV-positive patients

Feb. 13, 1998

Nutritional supplementation in HIV-infected patients

Feb. 13, 1998

Novel approach to HIV therapy described by ML Laboratories

Feb. 12, 1998

Panretin update

Feb. 12, 1998

Sustiva-containing combinations highly effective in reducing viral load in HIV-infected patients

Feb. 9, 1998

Promising laboratory findings and phase I results reported for Leukine

Feb. 6, 1998

Glaxo Wellcome's new NRTI highlighted at AIDS conference

Feb. 6, 1998

FddA demonstrates anti-HIV activity at well-tolerated doses in phase I trial

Feb. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...